Home LiteratureArticle Details
PMID: 1851533 Published · ppublish English Journal Article Review

Poxvirus pathogenesis.

Microbiological reviews ·Vol. 55 ·No. 1 ·1991-03-00 ·Pages 80-122

Buller RM, Palumbo GJ

Abstract

Poxviruses are a highly successful family of pathogens, with variola virus, the causative agent of smallpox, being the most notable member. Poxviruses are unique among animal viruses in several respects. First, owing to the cytoplasmic site of virus replication, the virus encodes many enzymes required either for macromolecular precursor pool regulation or for biosynthetic processes. Second, these viruses have a very complex morphogenesis, which involves the de novo synthesis of virus-specific membranes and inclusion bodies. Third, and perhaps most surprising of all, the genomes of these viruses encode many proteins which interact with host processes at both the cellular and systemic levels. For example, a viral homolog of epidermal growth factor is active in vaccinia virus infections of cultured cells, rabbits, and mice. At least five virus proteins with homology to the serine protease inhibitor family have been identified and one, a 38-kDa protein encoded by cowpox virus, is thought to block a host pathway for generating a chemotactic substance. Finally, a protein which has homology with complement components interferes with the activation of the classical complement pathway. Poxviruses infect their hosts by all possible routes: through the skin by mechanical means (e.g., molluscum contagiosum infections of humans), via the respiratory tract (e.g., variola virus infections of humans), or by the oral route (e.g., ectromelia virus infection of the mouse). Poxvirus infections, in general, are acute, with no strong evidence for latent, persistent, or chronic infections. They can be localized or systemic. Ectromelia virus infection of the laboratory mouse can be systemic but inapparent with no mortality and little morbidity, or highly lethal with death in 10 days. On the other hand, molluscum contagiosum virus replicates only in the stratum spinosum of the human epidermis, with little or no involvement of the dermis, and does not spread systemically from the site of infection. The host response to infection is progressive and multifactorial. Early in the infection process, interferons, the alternative pathway of complement activation, inflammatory cells, and natural killer cells may contribute to slowing the spread of the infection. The cell-mediated response involving learned cytotoxic T lymphocytes and delayed-type hypersensitivity components appears to be the most important in recovery from infection. A significant role for specific antiviral antibody and antibody-dependent cell-mediated cytotoxicity has yet to be demonstrated in recovery from a primary infection, but these responses are thought to be important in preventing reinfection.

MeSH Terms
Amino Acid Sequence Animals Growth Substances/chemistry Humans Intercellular Signaling Peptides and Proteins Molecular Sequence Data Peptides/chemistry Poxviridae/genetics,immunology,physiology Poxviridae Infections/microbiology Serpins/chemistry Virus Replication/genetics
Chemicals
Growth Substances Intercellular Signaling Peptides and Proteins Peptides Serpins vaccinia growth factor
Authors & Affiliations
2 authors, click to expand affiliations / ORCID
Buller R M
Laboratory of Viral Diseases, National Institute of Allergy and Infectious Diseases, Bethesda, Maryland 20892.
Palumbo G J
References (449)
449 references, click to expand
  1. Differential inhibitory effects of interferon on deoxythymidine kinase induction of vaccinia-infected cell cultures.
    Proc Soc Exp Biol Med. 1968 Jan;127(1):160-4 PMID: 5644637
  2. Biogenesis of vaccinia: evidence for more than 100 polypeptides in the virion.
    Virology. 1979 Jun;95(2):385-94 PMID: 462799
  3. Abortive replication of vaccinia virus in activated rabbit macrophages.
    Infect Immun. 1979 Oct;26(1):328-38 PMID: 500210
  4. Identification of the vaccinia hemagglutinin polypeptide from a cell system yielding large amounts of extracellular enveloped virus.
    J Virol. 1979 Jul;31(1):147-55 PMID: 501796
  5. Intragenomic sequence transposition in monkeypox virus.
    Virology. 1981 Mar;109(2):231-43 PMID: 6259807
  6. The role of the major histocompatibility complex in the adoptive transfer of ectromelia virus meningitis.
    J Neuropathol Exp Neurol. 1982 Jan;41(1):34-44 PMID: 6275037
  7. Analysis of Yaba tumor poxvirus-induced proteins in infected cells by two-dimensional gel electrophoresis.
    Virology. 1982 Jul 15;120(1):65-76 PMID: 6285603
  8. Malignant rabbit fibroma virus causes secondary immunosuppression in rabbits.
    J Immunol. 1983 Jan;130(1):399-404 PMID: 6292305
  9. Induction of resistance to ectromelia virus infection by corynebacterium parvum in murine peritoneal macrophages.
    J Reticuloendothel Soc. 1983 Jan;33(1):35-46 PMID: 6300395
  10. Immunohistology of malignant rabbit fibroma virus--a comparative study with rabbit myxoma virus.
    J Natl Cancer Inst. 1983 Jul;71(1):105-16 PMID: 6306322
  11. Natural killer cell depletion enhances virus synthesis and virus-induced hepatitis in vivo.
    J Immunol. 1983 Sep;131(3):1531-8 PMID: 6309965
  12. H-2-linked control of resistance to ectromelia virus infection in B10 congenic mice.
    Immunogenetics. 1983;18(3):255-65 PMID: 6311733
  13. Mechanisms of enhanced resistance of Mycobacterium bovis BCG-treated mice to ectromelia virus infection.
    Infect Immun. 1983 Nov;42(2):567-73 PMID: 6315580
  14. Vaccinia rescue of VSV from interferon-induced resistance: reversal of translation block and inhibition of protein kinase activity.
    Virology. 1983 Nov;131(1):128-36 PMID: 6316646
  15. Physical mapping of vaccinia virus temperature-sensitive mutations.
    Virology. 1983 Dec;131(2):385-93 PMID: 6318438
  16. The genome structure of cowpox virus white pock variants.
    J Gen Virol. 1984 May;65 ( Pt 5):875-86 PMID: 6327886
  17. The response of gut-associated T lymphocytes to intestinal viral immunization.
    J Immunol. 1984 Dec;133(6):2955-60 PMID: 6333450
  18. Heterogeneity of natural killer cells.
    Annu Rev Immunol. 1984;2:359-94 PMID: 6399848
  19. Protection against poxviruses.
    Proc R Soc Med. 1969 Mar 3;62(3):295-7 PMID: 4307230
  20. Macrophages and viral immunity.
    Semin Hematol. 1970 Apr;7(2):185-214 PMID: 4317324
  21. Biogenesis of vaccinia: separation of early stages from maturation by means of rifampicin.
    Virology. 1970 Apr;40(4):1039-51 PMID: 4317898
  22. Mechanisms of recovery from a generalized viral infection: mousepox. 3. Regression infectious foci.
    J Exp Med. 1971 May 1;133(5):1090-104 PMID: 4324301
  23. The morphogenesis of pigeonpox virus.
    J Gen Virol. 1972 Apr;15(1):79-83 PMID: 4337219
  24. Mechanism of interferon action: inhibition of viral messenger ribonucleic acid translation in L-cell extracts.
    J Virol. 1972 Dec;10(6):1184-98 PMID: 4345494
  25. Establishment and maintenance of the interferon-induced antiviral state: studies in enucleated cells.
    J Virol. 1974 Mar;13(3):623-30 PMID: 4362865
  26. Appearance of cytotoxic T cells in cerebrospinal fluid of mice with ectromelia virus-induced meningitis.
    Scand J Immunol. 1974;3(3):311-9 PMID: 4368424
  27. Interferon action: effect on the formation of poxvirus specific polysomes and viral RNA.
    Z Naturforsch B. 1970 Oct;25(10):1164-70 PMID: 4394875
  28. Selective increase in lymphocyte interferon response to vaccinia antigen after revaccination.
    Proc Natl Acad Sci U S A. 1972 Sep;69(9):2632-6 PMID: 4506785
  29. Cell-mediated cytotoxicity against ectromelia virus-infected target cells. II. Identification of effector cells and analysis of mechanisms.
    Eur J Immunol. 1974 Feb;4(2):68-72 PMID: 4546746
  30. Comparative studies on host responses to Shope fibroma virus in adult and newborn rabbits.
    J Natl Cancer Inst. 1973 Jun;50(6):1529-39 PMID: 4577768
  31. Cowpox in a dairy herd in the United Kingdom.
    Vet Rec. 1973 Jan 20;92(3):56-64 PMID: 4686118
  32. Role of lysosomes during infection with Shope fibroma virus of primary rabbit kidney tissue culture cells.
    J Gen Virol. 1974 Feb;22(2):249-53 PMID: 4820676
  33. Interferon gamma is involved in the recovery of athymic nude mice from recombinant vaccinia virus/interleukin 2 infection.
    J Exp Med. 1990 Nov 1;172(5):1495-503 PMID: 2121889
  34. Inflammatory responses and the generation of chemoattractant activity in cowpox virus-infected tissues.
    Immunology. 1990 Feb;69(2):202-8 PMID: 2155178
  35. Vaccinia virus host range genes.
    Virology. 1990 Nov;179(1):276-86 PMID: 2171207
  36. Inhibition of the complement cascade by the major secretory protein of vaccinia virus.
    Science. 1990 Nov 9;250(4982):827-30 PMID: 2237434
  37. Role of DNA replication in vaccinia virus gene expression: a naked template is required for transcription of three late trans-activator genes.
    Cell. 1990 Jun 1;61(5):801-9 PMID: 2344616
  38. Purification and characterization of vaccinia virus growth factor.
    Cell. 1985 Aug;42(1):383-93 PMID: 2410141
  39. Depression of protective mechanism during the early phase of a viral infection in tumor-bearing mice and prevention by PSK.
    Cancer Immunol Immunother. 1986;22(2):114-8 PMID: 2424596
  40. Regulation of virus infections by natural killer cells. A review.
    Nat Immun Cell Growth Regul. 1986;5(4):169-99 PMID: 2430177
  41. Rapid decrease in the levels of the double-stranded RNA-dependent protein kinase during virus infections.
    Virology. 1987 Jul;159(1):126-36 PMID: 2440179
  42. Molecular characterization of a prominent antigen of the vaccinia virus envelope.
    Virology. 1988 Dec;167(2):361-9 PMID: 2462305
  43. Tumor cells treated with vaccinia virus can activate the alternative pathway of mouse complement.
    Jpn J Cancer Res. 1989 Aug;80(8):765-70 PMID: 2511185
  44. Vaccinia virus encodes a thymidylate kinase gene: sequence and transcriptional mapping.
    Nucleic Acids Res. 1989 Oct 11;17(19):7581-90 PMID: 2552411
  45. Total haemolytic complement profile in chicks following fowl pox vaccination or infection.
    Acta Virol. 1989 Jan;33(1):87-90 PMID: 2565680
  46. Antibodies directed against a synthetic peptide enable detection of a protein encoded by a vaccinia virus host range gene that is conserved within the Orthopoxvirus genus.
    J Virol. 1989 Apr;63(4):1814-7 PMID: 2648026
  47. Mapping and insertional mutagenesis of a vaccinia virus gene encoding a 13,800-Da secreted protein.
    Virology. 1989 Aug;171(2):579-87 PMID: 2763467
  48. Vaccinia virus encodes a family of genes with homology to serine proteinase inhibitors.
    J Gen Virol. 1989 Sep;70 ( Pt 9):2333-43 PMID: 2778436
  49. Activated B cells can deliver help for the in vitro generation of antiviral cytotoxic T cells.
    Proc Natl Acad Sci U S A. 1989 Jun;86(12):4629-33 PMID: 2786634
  50. A role for early cytotoxic T cells in resistance to ectromelia virus infection in mice.
    J Gen Virol. 1987 Oct;68 ( Pt 10):2669-73 PMID: 2822845
  51. Herpes simplex virus type 1-induced ribonucleotide reductase activity is dispensable for virus growth and DNA synthesis: isolation and characterization of an ICP6 lacZ insertion mutant.
    J Virol. 1988 Jan;62(1):196-205 PMID: 2824847
  52. High levels of genetic recombination among cotransfected plasmid DNAs in poxvirus-infected mammalian cells.
    J Virol. 1988 Feb;62(2):367-75 PMID: 2826801
  53. Characterization of the transformation properties of Shope fibroma virus.
    Virus Res. 1988 Jan;9(1):33-48 PMID: 2829464
  54. Sequence analysis of an 11.2 kilobase, near-terminal, BamHI fragment of fowlpox virus.
    J Gen Virol. 1988 May;69 ( Pt 5):1025-40 PMID: 2836548
  55. DNA-dependent ATPase activity associated with vaccinia virus early transcription factor.
    J Biol Chem. 1988 Aug 5;263(22):10761-5 PMID: 2839505
  56. C3b receptor activity on transfected cells expressing glycoprotein C of herpes simplex virus types 1 and 2.
    J Virol. 1988 Nov;62(11):4027-36 PMID: 2845122
  57. Analysis of a large cluster of nonessential genes deleted from a vaccinia virus terminal transposition mutant.
    Virology. 1988 Dec;167(2):524-37 PMID: 2849238
  58. Conditional lethal mutants of rabbitpox virus. II. Mutants (p) that fail to multiply in PK-2a cells.
    Virology. 1966 Apr;28(4):600-9 PMID: 4957201
  59. Poxvirus specific cytopathic effect in interferon-treated L cells.
    Virology. 1971 Aug;45(2):456-62 PMID: 5106893
  60. Inactivated smallpox vaccine: immunogenicity of inactivated intracellular and extracellular vaccinia virus.
    J Gen Virol. 1971 Oct;13(1):19-25 PMID: 5130569
  61. RNA synthesis in vaccinia-infected L cells: inhibition of ribosome formation and maturation.
    Virology. 1971 Dec;46(3):730-44 PMID: 5167657
  62. Concerning the mechanism of action of interferon.
    Proc Natl Acad Sci U S A. 1966 Aug;56(2):558-65 PMID: 5229977
  63. Inhibition or enhancement of immunological injury of virus-infected cells.
    Proc Natl Acad Sci U S A. 1971 Dec;68(12):3073-7 PMID: 5316196
  64. Irreversible effects of cycloheximide during the early period of vaccinia virus replicaon.
    J Virol. 1970 Feb;5(2):99-108 PMID: 5444010
  65. Effect of interferon on deoxyribonuclease induction in chick fibroblast cultures infected with cowpox virus.
    J Virol. 1967 Jun;1(3):466-71 PMID: 5623968
  66. Mapping of a vaccinia host range sequence by insertion into the viral thymidine kinase gene.
    J Virol. 1985 Jan;53(1):316-8 PMID: 2981355
  67. Tumorigenic poxviruses: genomic organization of malignant rabbit virus, a recombinant between Shope fibroma virus and myxoma virus.
    Virology. 1985 Jan 15;140(1):113-24 PMID: 2981446
  68. Suppression by cyclosporin A of murine T-cell-mediated immunity against viruses in vivo and in vitro.
    Cell Immunol. 1985 Feb;90(2):464-73 PMID: 2981641
  69. Vaccinia as a model for membrane biogenesis.
    Virology. 1968 Aug;35(4):564-83 PMID: 5677800
  70. Vaccinia virus replication and cytopathic effect in cultures in phytohemagglutinin-treated human peripheral blood leukocytes.
    J Virol. 1968 Aug;2(8):787-92 PMID: 5701820
  71. Double-stranded RNA in vaccinia virus infected cells.
    Nature. 1969 Jun 7;222(5197):940-4 PMID: 5789322
  72. Molluscum contagiosum: normal and virus infected epidermal cell kinetics.
    J Invest Dermatol. 1966 Jan;46(1):91-103 PMID: 5905255
  73. Experiences with improvement of the neutralization reaction with vaccinia virus in chick fibroblast cultures.
    J Hyg Epidemiol Microbiol Immunol. 1966;10(4):488-98 PMID: 6006816
  74. Molluscum contagiosum in chimpanzees.
    J Am Vet Med Assoc. 1967 Oct 1;151(7):901-4 PMID: 6070316
  75. Spontaneous deletions and duplications of sequences in the genome of cowpox virus.
    Proc Natl Acad Sci U S A. 1984 Nov;81(21):6817-21 PMID: 6093123
  76. Inductive requirements for the generation of virus-specific T lymphocytes. II. Poxvirus and H-2 antigens associate without cellular or virus-directed protein synthesis, and remain immunogenic in cell membrane fragments.
    J Immunol. 1980 Apr;124(4):1990-6 PMID: 6154087
  77. Comparative antiviral efficiency of leukocyte and bacterially produced human alpha-interferon in rhesus monkeys.
    Nature. 1981 Aug 20;292(5825):775-6 PMID: 6167863
  78. Inhibition of cellular protein synthesis by vaccinia virus surface tubules.
    Virology. 1982 Jan 15;116(1):137-47 PMID: 6175073
  79. Human plasma proteinase inhibitors.
    Annu Rev Biochem. 1983;52:655-709 PMID: 6193754
  80. Immunologic dysfunction during viral oncogenesis. I. Nonspecific immunosuppression caused by malignant rabbit fibroma virus.
    J Immunol. 1983 Nov;131(5):2595-600 PMID: 6195270
  81. The inhibition of HeLa cell RNA synthesis following infection with vaccinia virus.
    J Gen Virol. 1984 Oct;65 ( Pt 10):1687-97 PMID: 6208316
  82. Symmetrical arrangement of the heterologous regions of rabbit poxvirus and vaccinia virus DNA.
    J Gen Virol. 1980 Apr;47(2):385-98 PMID: 6245176
  83. Deletions of the terminal sequences in the genomes of the white pock (u) and host-restricted (p) mutants of rabbitpox virus.
    J Gen Virol. 1980 May;48(1):135-47 PMID: 6247433
  84. The white pock mutants of rabbit poxvirus. II. The early white pock (mu) host range (hr) mutants of rabbit poxvirus uncouple transcription and translation in nonpermissive cells.
    Virology. 1980 Oct 30;106(2):234-49 PMID: 6254249
  85. Biogenesis of vaccinia: involvement of spicules of the envelope during virion assembly examined by means of conditional lethal mutants and serology.
    Virology. 1982 Apr 30;118(2):279-92 PMID: 7090181
  86. Inhibition of protein synthesis by vaccinia virus. IV. The role of low-molecular-weight viral RNA in the inhibition of protein synthesis.
    Virology. 1981 Jul 15;112(1):13-24 PMID: 7245615
  87. Unit Complex of vaccinia polypeptides linked by disulfide bridges.
    Virology. 1981 Aug;113(1):277-84 PMID: 7269243
  88. Immune response to acute virus infection in the Syrian hamster. I. Studies on genetic restriction of cell-mediated cytotoxicity.
    Immunogenetics. 1980;10(2):185-99 PMID: 7419247
  89. Significance of extracellular enveloped virus in the in vitro and in vivo dissemination of vaccinia.
    J Gen Virol. 1980 Sep;50(1):89-100 PMID: 7441216
  90. Spontaneous mutation of cowpox-virus by means of egg-passage.
    Arch Gesamte Virusforsch. 1952;5(1):35-52 PMID: 13031551
  91. Resistance to fibroma virus infection; the role of immune leukocytes and immune macrophages.
    J Exp Med. 1955 Jan 1;101(1):43-58 PMID: 13211926
  92. Morphology of resting vaccinia virus.
    Nature. 1956 Dec 29;178(4548):1453-5 PMID: 13387736
  93. [Electron microscopy of the virus of molluscum contagiosum].
    C R Hebd Seances Acad Sci. 1958 May 28;246(21):3133-6 PMID: 13547555
  94. An outbreak of subcutaneous tumours in rhesus monkeys.
    Nature. 1958 Jul 19;182(4629):195-6 PMID: 13566242
  95. Arthropod transmission of rabbit fibromatosis (Shope).
    J Hyg (Lond). 1959 Mar;57(1):1-30 PMID: 13641652
  96. The antibody response to smallpox vaccination as measured by a tissue culture plaque method.
    J Immunol. 1960 Sep;85:275-83 PMID: 13718978
  97. Studies on the innate resistance of mice to infection with mousepox. I. Resistance and antibody production.
    Aust J Exp Biol Med Sci. 1960 Aug;38:271-88 PMID: 13747446
  98. The initiation of vaccinia infection.
    Virology. 1960 Jul;11:603-23 PMID: 13806834
  99. Characterization of a specific kinase inhibitory factor produced by vaccinia virus which inhibits the interferon-induced protein kinase.
    Virology. 1984 Aug;137(1):171-81 PMID: 6474831
  100. Abortive ectromelia virus infection in peritoneal macrophages activated by Corynebacterium parvum.
    J Leukoc Biol. 1984 Feb;35(2):179-92 PMID: 6584516
  101. Biogenesis of poxviruses: further evidence for inhibition of host and virus DNA synthesis by a component of the invading inoculum particle.
    Virology. 1974 Apr;58(2):377-86 PMID: 4856571
  102. Molluscum contagiosum -- a defective poxvirus?
    J Gen Virol. 1976 Nov;33(2):281-95 PMID: 11275
  103. The cell-mediated immune response to ectromelia virus infection. I. Kinetics and characteristics of the primary effector T cell response in vivo.
    Cell Immunol. 1976 Mar 15;22(2):271-82 PMID: 58730
  104. Cooperation between mouse T-cell subpopulations in the cell-mediated response to a natural poxvirus pathogen.
    Cell Immunol. 1976 Oct;26(2):153-9 PMID: 61822
  105. Cytotoxic cells induced during lymphocytic choriomeningitis virus infection of mice. II. "Specificities" of the natural killer cells.
    J Immunol. 1979 Feb;122(2):475-81 PMID: 84023
  106. Cytotoxic macrophages induced in hamsters by vaccinia virus: selective cytotoxicity for virus-infected targets by macrophages collected late after immunization.
    J Immunol. 1979 Jul;123(1):303-10 PMID: 87476
  107. Cell-mediated cytotoxicity during vaccinia virus revaccination in man: influence of antibodies and interferon.
    Scand J Immunol. 1979;10(6):543-8 PMID: 94462
  108. Reproduction of vaccinia virus (strain neurolapina) in rabbit blood leucocytes in vitro.
    J Hyg Epidemiol Microbiol Immunol. 1975;19(1):93-104 PMID: 165236
  109. Changes in the surface of virus-induced cells recognized by cytotoxic T cells. I. Minimal requirements for lysis of ectromelia-infected P-815 cells.
    Scand J Immunol. 1976;5(1-2):23-30 PMID: 178048
  110. The cell-mediated immune response to ectromelia virus infection. II. Secondary response in vitro and kinetics of memory T cell production in vivo.
    Cell Immunol. 1976 Mar 15;22(2):283-96 PMID: 179718
  111. Rescue of vesicular stomatitis virus from homologous and heterologous interferon-induced resistance in human cell cultures by poxviruses.
    Infect Immun. 1976 Jul;14(1):311-4 PMID: 181327
  112. Effect of selective complement deficiency on the rate of neutralization of enveloped viruses by human sera.
    J Immunol. 1977 Jan;118(1):28-34 PMID: 187701
  113. Cytotoxic T cells in the peritoneal cavity of mice infected with ectromelia virus.
    Aust J Exp Biol Med Sci. 1976 Aug;54(4):365-70 PMID: 189743
  114. Outbreak of pox disease among carnivora (felidae) and edentata.
    J Infect Dis. 1977 Mar;135(3):358-66 PMID: 191538
  115. Comparison of five poxvirus genomes by analysis with restriction endonucleases HindIII, BamI and EcoRI.
    J Gen Virol. 1978 Jan;38(1):135-47 PMID: 202667
  116. Identification and study of a poxvirus isolated from wild rodents in Turkmenia.
    Arch Virol. 1978;56(1-2):7-14 PMID: 204271
  117. Interferon action may be mediated by activation of a nuclease by pppA2'p5'A2'p5'A.
    Nature. 1978 Jun 22;273(5664):684-7 PMID: 208001
  118. Effect of Mycobacterium tuberculosis BCG infection on the resistance of mice to ectromelia virus infection: participation of interferon in enhanced resistance.
    Infect Immun. 1978 Apr;20(1):312-4 PMID: 208973
  119. Conservation and variation in Orthopoxvirus genome structure.
    J Gen Virol. 1979 Dec;45(3):683-701 PMID: 232137
  120. Antiviral protection by virus-immune cytotoxic T cells: infected target cells are lysed before infectious virus progeny is assembled.
    J Exp Med. 1977 Mar 1;145(3):644-51 PMID: 233908
  121. In vitro inhibition of protein synthesis by purified cores from vaccinia virus.
    Proc Natl Acad Sci U S A. 1978 Jan;75(1):175-9 PMID: 272632
  122. pppA2'p5'A2'p5'A: an inhibitor of protein synthesis synthesized with an enzyme fraction from interferon-treated cells.
    Proc Natl Acad Sci U S A. 1978 Jan;75(1):256-60 PMID: 272640
  123. Immune response in humans after vaccination with vaccinia virus: generation of a virus-specific cytotoxic activity by human peripheral lymphocytes.
    J Exp Med. 1977 Oct 1;146(4):949-69 PMID: 302316
  124. Inhibition of host protein synthesis in vaccinia virus-infected cells in the presence of cordycepin (3'-deoxyadenosine).
    J Virol. 1978 Jan;25(1):11-8 PMID: 304489
  125. Host range restriction of vaccinia virus in Chinese hamster ovary cells: relationship to shutoff of protein synthesis.
    J Virol. 1978 Dec;28(3):843-50 PMID: 310474
  126. Meningeal exudate cells in vaccinia meningitis of mice: role of local T cells.
    Infect Immun. 1978 Jun;20(3):752-9 PMID: 352957
  127. Cell-mediated immune response to lymphocytic choriomeningitis and vaccinia virus in rats.
    J Immunol. 1977 Oct;119(4):1242-7 PMID: 408419
  128. Further studies on a vaccinia virus cytotoxin present in infected cell extracts: identification as surface tubule monomer and possible mode of action.
    Arch Virol. 1979;59(1-2):107-19 PMID: 426631
  129. Biogenesis of poxviruses: transitory expression of Molluscum contagiosum early functions.
    Virology. 1979 Apr 30;94(2):297-313 PMID: 452419
  130. Vaccinia virus encodes a polypeptide homologous to epidermal growth factor and transforming growth factor.
    Nature. 1985 Feb 7-13;313(6002):491-2 PMID: 3871510
  131. Similarity between the vaccinia virus 19K early protein and epidermal growth factor.
    Nature. 1985 Feb 28-Mar 6;313(6005):801-3 PMID: 3871916
  132. Vaccinia virus-infected cells release a novel polypeptide functionally related to transforming and epidermal growth factors.
    Proc Natl Acad Sci U S A. 1985 Aug;82(16):5300-4 PMID: 3875097
  133. Restriction endonuclease analysis of red cowpox virus and its white pock variant.
    J Gen Virol. 1979 Oct;45(1):51-63 PMID: 521806
  134. Phosphorylation of initiation factor elF-2 and the control of reticulocyte protein synthesis.
    Cell. 1977 May;11(1):187-200 PMID: 559547
  135. Biogenesis of poxviruses: glycolipid metabolism in vaccinia-infected cells.
    Virology. 1978 Jan;84(1):108-17 PMID: 619485
  136. Humoral and cell-mediated immune responses in humans before and after revaccination with vaccinia virus.
    Infect Immun. 1978 Jan;19(1):34-9 PMID: 624594
  137. Studies on the mechanisms of vaccinia virus cytopathic effects. II. Early cell rounding is associated with virus polypeptide synthesis.
    J Gen Virol. 1978 Jun;39(3):403-13 PMID: 660161
  138. Adsorption and penetration of enveloped and naked vaccinia virus particles.
    J Virol. 1978 Jul;27(1):19-27 PMID: 691111
  139. Polypeptide composition of extracellular enveloped vaccinia virus.
    J Virol. 1978 Jul;27(1):28-37 PMID: 691112
  140. Further investigations on the mode of entry of vaccinia virus into cells.
    J Gen Virol. 1976 Aug;32(2):275-82 PMID: 798024
  141. Cytotoxic T cells recognize very early, minor changes in ectromelia virus-infected target cells.
    Aust J Exp Biol Med Sci. 1976 Aug;54(4):349-63 PMID: 828047
  142. Lymphocyte-virus interactions. Identification of a restriction fragment permitting virus replication in lymphocytes.
    J Immunol. 1988 Mar 15;140(6):2060-7 PMID: 2894396
  143. Characterization of intermediates in the uncoating of vaccinia virus DNA.
    Virology. 1972 Nov;50(2):593-602 PMID: 4117938
  144. Vaccinia Gangrenosa with normal humoral antibodies. A case possibly due to deficient cellular immunity treated with N-methylisatin beta-thiosemicarbazone (Compound 33T57, Marboran).
    Acta Paediatr Scand. 1966 May;55(3):264-72 PMID: 4163795
  145. Cell-mediated cytotoxicity against ectromelia virus-infected target cells. I. Specificity and kinetics.
    Eur J Immunol. 1974 Feb;4(2):63-7 PMID: 4211857
  146. The fine structure of the Yaba monkey tumor poxvirus.
    Cancer Res. 1966 May;26(5):995-1008 PMID: 4286870
  147. Resistance to alveolar monocytes to rabbitpox virus following intratracheal injection of parainfluenza-3 virus.
    J Reticuloendothel Soc. 1968 Feb;5(1):68-78 PMID: 4297091
  148. A study of the possible basis of age-dependent resistance of mice to poxvirus diseases.
    Aust J Exp Biol Med Sci. 1968 Jun;46(3):251-65 PMID: 4300505
  149. Lysis mediated by T cells and restricted by H-2 antigen of target cells infected with vaccinia virus.
    Nature. 1975 Jun 12;255(5509):552-4 PMID: 1079922
  150. Cell-medicated cytotoxicity against ectromelia virus-infected target cells. III. Role of the H-2 gene complex.
    Eur J Immunol. 1975 Feb;5(2):122-7 PMID: 1086219
  151. Target cell-dependent T cell-mediated lysis of vaccinia virus-infected cells.
    Eur J Immunol. 1975 Apr;5(4):245-51 PMID: 1086229
  152. Inhibition of host protein synthesis by vaccinia virus: fate of cell mRNA and synthesis of small poly (A)-rich polyribonucleotides in the presence of actinomycin D.
    J Virol. 1975 Jul;16(1):34-42 PMID: 1133878
  153. Early interactions of the virus Molluscum contagiosum with its host cell. Virus-induced alterations in the basal and suprabasal layers of the epidermis.
    J Ultrastruct Res. 1976 Jan;54(1):37-52 PMID: 1249846
  154. Increased endonuclease activity in an extract from mouse Ehrlich ascites tumor cells which had been treated with a partially purified interferon preparation: dependence of double-stranded RNA;.
    Biochem Biophys Res Commun. 1976 Mar 8;69(1):114-22 PMID: 1259747
  155. Deletion of 55 open reading frames from the termini of vaccinia virus.
    Virology. 1991 Jan;180(1):406-10 PMID: 1984660
  156. Analysis of cDNA for human erythrocyte ankyrin indicates a repeated structure with homology to tissue-differentiation and cell-cycle control proteins.
    Nature. 1990 Mar 1;344(6261):36-42 PMID: 2137557
  157. Insertional inactivation of the large subunit of ribonucleotide reductase encoded by vaccinia virus is associated with reduced virulence in vivo.
    Virology. 1990 Feb;174(2):625-9 PMID: 2154895
  158. Molecular analysis of immunosuppression induced by virus replication in lymphocytes.
    J Immunol. 1990 May 15;144(10):3992-9 PMID: 2159037
  159. Regulation of vaccinia virus transcription.
    Annu Rev Biochem. 1990;59:661-88 PMID: 2197987
  160. The complete DNA sequence of vaccinia virus.
    Virology. 1990 Nov;179(1):247-66, 517-63 PMID: 2219722
  161. Elevated natural killer cell responses in mice infected with recombinant vaccinia virus encoding murine IL-2.
    J Immunol. 1990 Jan 1;144(1):290-8 PMID: 2295796
  162. Fusion of intra- and extracellular forms of vaccinia virus with the cell membrane.
    J Virol. 1990 Oct;64(10):4884-92 PMID: 2398531
  163. An in vitro measure of cellular immunity to fibroma virus.
    J Immunol. 1970 Feb;104(2):502-10 PMID: 4904883
  164. The effect of thiosemicarbazones on the growth of rabbit pox virus in tissue culture.
    Ann N Y Acad Sci. 1965 Jul 30;130(1):92-104 PMID: 4955272
  165. Role of interferon in lymphocyte recruitment into the skin.
    Cell Immunol. 1986 May;99(2):322-33 PMID: 2428532
  166. Vaccinia virus growth factor stimulates tyrosine protein kinase activity of A431 cell epidermal growth factor receptors.
    Mol Cell Biol. 1986 Jan;6(1):332-6 PMID: 2431267
  167. Modification of vaccinia virus penetration proteins analyzed by monoclonal antibodies.
    Virology. 1987 Apr;157(2):449-59 PMID: 2435058
  168. [Potentiation of the antiviral activity of human interferons by virazole in in vitro experiments].
    Vopr Virusol. 1987 Sep-Oct;32(5):570-3 PMID: 2448957
  169. Evidence that NK cells and interferon are required for genetic resistance to lethal infection with ectromelia virus.
    Arch Virol. 1989;108(1-2):49-58 PMID: 2480764
  170. Role of lymphokine-secreting CD8+ T cells in cytotoxic T lymphocyte responses against vaccinia virus.
    J Immunol. 1989 Jan 1;142(1):270-3 PMID: 2521235
  171. Effects of treatment with IL-2 receptor specific monoclonal antibody in mice. Inhibition of cytotoxic T cell responses but not of T help.
    J Immunol. 1989 Jul 15;143(2):628-32 PMID: 2544648
  172. Shope fibroma: a model system to study tumorigenesis by poxviruses.
    Ann N Y Acad Sci. 1989;567:222-33 PMID: 2552890
  173. Treatment of mice with polyinosinic-polycytidilic polyribonucleotide reduces T-cell involvement in a localized inflammatory response to vaccinia virus challenge.
    J Virol. 1985 Feb;53(2):489-94 PMID: 2578572
  174. Humoral and cell-mediated immune responses to recombinant vaccinia viruses in mice.
    Immunol Cell Biol. 1989 Oct;67 ( Pt 5):331-7 PMID: 2613280
  175. Intramolecular homologous recombination in cells infected with temperature-sensitive mutants of vaccinia virus.
    J Virol. 1989 May;63(5):2030-5 PMID: 2704074
  176. Inhibition of an inflammatory response is mediated by a 38-kDa protein of cowpox virus.
    Virology. 1989 Sep;172(1):262-73 PMID: 2773318
  177. Fatty acid acylation of vaccinia virus proteins.
    J Virol. 1989 Oct;63(10):4285-91 PMID: 2778876
  178. Vaccinia virus encodes two proteins that are structurally related to members of the plasma serine protease inhibitor superfamily.
    J Virol. 1989 Feb;63(2):600-6 PMID: 2783466
  179. Mousepox in inbred mice innately resistant or susceptible to lethal infection with ectromelia virus. V. Genetics of resistance to the Moscow strain.
    Arch Virol. 1989;107(1-2):35-41 PMID: 2803004
  180. Mapping and nucleotide sequence of the vaccinia virus gene that encodes a 14-kilodalton fusion protein.
    J Virol. 1987 Nov;61(11):3550-4 PMID: 2822962
  181. Molluscum contagiosum: characterization of viral DNA and clinical features.
    Epidemiol Infect. 1987 Oct;99(2):563-6 PMID: 2824227
  182. Selective inhibition of protein synthesis by synthetic and vaccinia virus-core synthesized poly(riboadenylic acids).
    Virology. 1987 Dec;161(2):366-73 PMID: 2825410
  183. Vaccinia virus-encoded ribonucleotide reductase: sequence conservation of the gene for the small subunit and its amplification in hydroxyurea-resistant mutants.
    J Virol. 1988 Feb;62(2):519-27 PMID: 2826813
  184. Immunosuppression during viral oncogenesis. IV. Generation of soluble virus-induced immunologic suppressor molecules.
    J Immunol. 1988 Mar 15;140(6):2051-9 PMID: 2831278
  185. A cowpox virus gene required for multiplication in Chinese hamster ovary cells.
    J Virol. 1988 Apr;62(4):1297-304 PMID: 2831390
  186. Immunosuppression during viral oncogenesis. V. Resistance to virus-induced immunosuppressive factor.
    J Immunol. 1988 Jul 1;141(1):347-51 PMID: 2837511
  187. Mousepox in inbred mice innately resistant or susceptible to lethal infection with ectromelia virus. IV. Studies with the Moscow strain.
    Arch Virol. 1988;100(3-4):221-30 PMID: 2840874
  188. Tumorigenic poxviruses: fine analysis of the recombination junctions in malignant rabbit fibroma virus, a recombinant between Shope fibroma virus and myxoma virus.
    Virology. 1988 Sep;166(1):229-39 PMID: 2842947
  189. Synthesis of a biological active tumor growth factor from the predicted DNA sequence of Shope fibroma virus.
    Biochemistry. 1988 Jul 26;27(15):5640-5 PMID: 2846046
  190. Poxvirus deletion mutants: virulence and immunogenicity.
    Microb Pathog. 1988 May;4(5):325-33 PMID: 2853813
  191. Studies on poxvirus infection in cats.
    Arch Virol. 1989;104(1-2):19-33 PMID: 2923548
  192. Role of L3T4 antigen in the activation of various functions of Lyt-1+2- T cells against vaccinia virus.
    Microbiol Immunol. 1986;30(8):799-810 PMID: 2946922
  193. Natural killer cells vs cytotoxic T cells in the peripheral blood of virus-infected mice.
    J Immunol. 1985 Jan;134(1):598-602 PMID: 2981094
  194. Effect of interferon on the dynamics of H3-thymidine incorporation and thymidine kinase induction in chick fibroblast cultures infected with vaccinia virus.
    Virology. 1965 Oct;27(2):186-92 PMID: 5840890
  195. Controlled degradation of vaccinia virions in vitro: an electron microscopic study.
    J Ultrastruct Res. 1966 Mar;14(5):484-96 PMID: 5930347
  196. Effect of interferon on early enzyme and viral DNA synthesis in vaccinia virus infections.
    Virology. 1967 May;32(1):33-40 PMID: 6025067
  197. Kinetics of ectromelia virus (mousepox) transmission and clinical response in C57BL/6j, BALB/cByj and AKR/J inbred mice.
    Lab Anim Sci. 1985 Feb;35(1):41-6 PMID: 2984458
  198. Generation of a dominant 8-MDa deletion at the left terminus of vaccinia virus DNA.
    Proc Natl Acad Sci U S A. 1985 May;82(10):3365-9 PMID: 2987924
  199. Genetic determinants of resistance to ectromelia (mousepox) virus-induced mortality.
    J Virol. 1985 Sep;55(3):890-1 PMID: 2991610
  200. Similarity of vaccinia 28K, v-erb-B and EGF receptors.
    Nature. 1985 Jul 18-24;316(6025):219-20 PMID: 2991765
  201. In vitro growth of two related leporipoxviruses in lymphoid cells.
    Virology. 1985 Sep;145(2):330-4 PMID: 2992155
  202. Transcription of vaccinia virus early genes by a template-dependent soluble extract of purified virions.
    J Virol. 1985 Nov;56(2):349-55 PMID: 2997463
  203. Orthopoxvirus DNA: a comparison of restriction profiles and maps.
    Virology. 1985 May;143(1):230-51 PMID: 2998003
  204. Effect of complement depletion by cobra venom factor on fowlpox virus infection in chickens and chicken embryos.
    J Virol. 1986 Feb;57(2):670-3 PMID: 3003397
  205. Detection of a subunit of cellular Pol II within highly purified preparations of RNA polymerase isolated from rabbit poxvirus virions.
    Cell. 1986 Feb 28;44(4):587-96 PMID: 3004740
  206. Graft-versus-host reactions in F1 hybrid mice: MHC-restriction-independent generalized depression of virus-specific cytotoxic T cell response.
    Immunobiology. 1984 May;166(3):308-17 PMID: 6610629
  207. Vaccinia virus induces cellular mRNA degradation.
    J Virol. 1983 Sep;47(3):529-39 PMID: 6620463
  208. Cellular differences in the molecular mechanisms of vaccinia virus host range restriction.
    J Gen Virol. 1980 Apr;47(2):485-8 PMID: 6767809
  209. The response of human lymphocyte subpopulations to measles, mumps, and vaccinia viral antigens.
    J Immunol. 1980 Jul;125(1):221-5 PMID: 6966650
  210. Role of the H-2I region in the generation of an antiviral cytotoxic T-cell response in vitro.
    Cell Immunol. 1980 Aug 1;53(2):285-97 PMID: 6967766
  211. Immune response to acute virus infection in the Syrian hamster. II. Studies on the identity of virus-induced cytotoxic effector cells.
    J Immunol. 1981 Jan;126(1):214-8 PMID: 7005334
  212. Biogenesis of vaccina: interrelationship between post-translational cleavage, virus assembly, and maturation.
    Virology. 1982 Mar;117(2):341-56 PMID: 7039091
  213. Virus-lymphocyte interactions during the course of immunosuppressive virus infection.
    J Gen Virol. 1987 Feb;68 ( Pt 2):463-72 PMID: 3029285
  214. Characterization and physical mapping of Molluscum contagiosum virus DNA and location of a sequence capable of encoding a conserved domain of epidermal growth factor.
    J Gen Virol. 1987 Mar;68 ( Pt 3):673-82 PMID: 3029297
  215. Mapping and sequencing of a gene from myxoma virus that is related to those encoding epidermal growth factor and transforming growth factor alpha.
    J Virol. 1987 Apr;61(4):1271-5 PMID: 3029424
  216. The genome of Shope fibroma virus, a tumorigenic poxvirus, contains a growth factor gene with sequence similarity to those encoding epidermal growth factor and transforming growth factor alpha.
    Mol Cell Biol. 1987 Jan;7(1):535-40 PMID: 3031480
  217. Growth of malignant rabbit fibroma virus in lymphoid cells.
    Virology. 1987 May;158(1):147-57 PMID: 3033886
  218. Mousepox in inbred mice innately resistant or susceptible to lethal infection with ectromelia virus. II. Pathogenesis.
    Lab Anim Sci. 1987 Feb;37(1):16-22 PMID: 3035274
  219. Mousepox in inbred mice innately resistant or susceptible to lethal infection with ectromelia virus. III. Experimental transmission of infection and derivation of virus-free progeny from previously infected dams.
    Lab Anim Sci. 1987 Feb;37(1):23-7 PMID: 3035275
  220. Observations on the replication of ectromelia virus in mouse-derived cell lines: implications for epidemiology of mousepox.
    Lab Anim Sci. 1987 Feb;37(1):28-32 PMID: 3035276
  221. Inhibition of epidermal growth factor-induced cellular proliferation.
    Am J Pathol. 1987 Aug;128(2):203-9 PMID: 3039847
  222. The biology and enzymology of eukaryotic protein acylation.
    Annu Rev Biochem. 1988;57:69-99 PMID: 3052287
  223. One-signal requirement for interferon-gamma production by human large granular lymphocytes.
    J Immunol. 1987 Aug 1;139(3):724-7 PMID: 3110282
  224. Gamma-interferon is produced by CD3+ and CD3- lymphocytes.
    Immunol Rev. 1987 Jun;97:51-65 PMID: 3114127
  225. Prevention of vaccinia virus infection in immunodeficient mice by vector-directed IL-2 expression.
    Nature. 1987 Nov 19-25;330(6145):259-62 PMID: 3118219
  226. Plasminogen activator inhibitors--a review.
    Enzyme. 1988;40(2-3):113-21 PMID: 3139400
  227. The reactivation of poxviruses. II. The range of reactivating viruses.
    Virology. 1960 May;11:185-201 PMID: 13822174
  228. Value of serotherapy in a virus disease (rabbit pox).
    Lancet. 1961 Nov 4;2(7210):1012-5 PMID: 13871833
  229. Effects and virulences of recombinant vaccinia viruses derived from attenuated strains that express the human T-cell leukemia virus type I envelope gene.
    J Virol. 1988 Dec;62(12):4474-80 PMID: 3184271
  230. Non-essential genes in the vaccinia virus HindIII K fragment: a gene related to serine protease inhibitors and a gene related to the 37K vaccinia virus major envelope antigen.
    J Gen Virol. 1988 Dec;69 ( Pt 12):2995-3003 PMID: 3264331
  231. The role of the host cell nucleus in vaccinia virus morphogenesis.
    Virus Res. 1987 Sep;8(3):173-91 PMID: 3318210
  232. Delineation of the viral products of recombination in vaccinia virus-infected cells.
    J Virol. 1988 Mar;62(3):1046-54 PMID: 3339712
  233. Deletion of the vaccinia virus growth factor gene reduces virus virulence.
    J Virol. 1988 Mar;62(3):866-74 PMID: 3339716
  234. Cell proliferative response to vaccinia virus is mediated by VGF.
    Virology. 1988 May;164(1):182-92 PMID: 3363864
  235. Purification of a factor required for transcription of vaccinia virus early genes.
    J Biol Chem. 1988 Aug 5;263(22):10754-60 PMID: 3392040
  236. Vaccinia virus encodes a secretory polypeptide structurally related to complement control proteins.
    Nature. 1988 Sep 8;335(6186):176-8 PMID: 3412473
  237. Vaccinia virus gene D8 encodes a virion transmembrane protein.
    J Virol. 1988 Oct;62(10):3772-8 PMID: 3418784
  238. Isolation of cowpox virus A-type inclusions and characterization of their major protein component.
    Virology. 1986 Mar;149(2):174-89 PMID: 3456179
  239. Localization and sequence of a vaccinia virus gene required for multiplication in human cells.
    Proc Natl Acad Sci U S A. 1986 Aug;83(15):5573-7 PMID: 3461450
  240. Oligonucleotide sequence signaling transcriptional termination of vaccinia virus early genes.
    Proc Natl Acad Sci U S A. 1987 Sep;84(18):6417-21 PMID: 3476956
  241. Effect of rabbit anti-asialo GM1 treatment in vivo or with anti-asialo GM1 plus complement in vitro on cytotoxic T cell activities.
    J Immunol. 1986 Jun 15;136(12):4674-80 PMID: 3486908
  242. Vaccinia virus proteins on the plasma membranes of infected cells. IV. Studies employing L cells infected with ultraviolet-irradiated vaccinia virions.
    Virology. 1986 Jul 30;152(2):331-42 PMID: 3487879
  243. Temporal regulation of influenza hemagglutinin expression in vaccinia virus recombinants and effects on the immune response.
    Eur J Immunol. 1986 Dec;16(12):1479-87 PMID: 3493144
  244. Recovery of immunodeficient mice from a vaccinia virus/IL-2 recombinant infection.
    Nature. 1987 Oct 8-14;329(6139):545-6 PMID: 3498904
  245. Mechanism of cytotoxicity by natural killer (NK) cells.
    Annu Rev Immunol. 1986;4:651-80 PMID: 3518752
  246. Hemorrhage in lesions caused by cowpox virus is induced by a viral protein that is related to plasma protein inhibitors of serine proteases.
    Proc Natl Acad Sci U S A. 1986 Oct;83(20):7698-702 PMID: 3532120
  247. Suppressive effects of B-lactam-antibiotics on in vitro generation of cytotoxic T-cells.
    Int J Immunopharmacol. 1986;8(7):723-9 PMID: 3536767
  248. Depression of virus-specific cytotoxic T-cell responses during murine malaria.
    Parasite Immunol. 1987 Mar;9(2):161-74 PMID: 3554117
  249. The assay, purification and properties of vaccinia virus-induced uncoating protein.
    J Gen Virol. 1987 Apr;68 ( Pt 4):1021-8 PMID: 3572355
  250. High-frequency homologous recombination in vaccinia virus DNA.
    J Virol. 1987 Jun;61(6):1788-95 PMID: 3573150
  251. Misreading of DNA templates containing 8-hydroxydeoxyguanosine at the modified base and at adjacent residues.
    Nature. 1987 May 7-13;327(6117):77-9 PMID: 3574469
  252. Sensitization of human tumor cells to homologous complement by vaccinia virus treatment.
    Cancer Immunol Immunother. 1987;25(1):7-9 PMID: 3594492
  253. Neutrophil uptake of vaccinia virus in vitro.
    J Infect Dis. 1987 Oct;156(4):597-606 PMID: 3624906
  254. Purification and characterization of a protein synthesis inhibitor associated with vaccinia virus.
    J Biol Chem. 1986 Jun 25;261(18):8283-9 PMID: 3636342
  255. Localization and fine structure of a vaccinia virus gene encoding an envelope antigen.
    J Virol. 1986 Jun;58(3):757-64 PMID: 3701927
  256. Studies on the mechanism of entry of vaccinia virus in animal cells.
    Arch Virol. 1987;92(1-2):135-50 PMID: 3800657
  257. A 14,000-Mr envelope protein of vaccinia virus is involved in cell fusion and forms covalently linked trimers.
    J Virol. 1987 Feb;61(2):395-404 PMID: 3806791
  258. The toxic effect of vaccinia virus on leucocytes in vitro.
    J Immunol. 1958 Dec;81(6):460-6 PMID: 13611251
  259. The toxic activity of vaccinia virus in tissue culture.
    J Infect Dis. 1959 Mar-Apr;104(2):193-202 PMID: 13654808
  260. Mechanism of recovery from viral infection in the chick embryo.
    Nature. 1961 Jul 1;191:97-8 PMID: 13687199
  261. Characteristics of lymphoblasts appearing in efferent lymph in response to immunization with vaccinia virus.
    Immunology. 1985 Sep;56(1):23-31 PMID: 3876275
  262. Vaccinia virus proteins on the plasma membrane of infected cells. III. Infection of peritoneal macrophages.
    Virology. 1985 Dec;147(2):354-72 PMID: 3878029
  263. Mode of sensitivity and resistance of vaccinia virus replication to interferon.
    J Gen Virol. 1986 Apr;67 ( Pt 4):801-8 PMID: 3958696
  264. Extracellular release of enveloped vaccinia virus from mouse nasal epithelial cells in vivo.
    J Gen Virol. 1985 Mar;66 ( Pt 3):643-6 PMID: 3973566
  265. Antiviral effect of bacterially produced human interferon (Hu-IFN alpha 2) against experimental vaccinia infection in calves.
    J Interferon Res. 1985 Winter;5(1):129-36 PMID: 3989335
  266. Golgi-derived membranes that contain an acylated viral polypeptide are used for vaccinia virus envelopment.
    J Virol. 1985 Sep;55(3):651-9 PMID: 4020961
  267. Ectromelia virus-induced changes in primary cultures of mouse hepatocytes.
    J Gen Virol. 1985 Oct;66 ( Pt 10):2171-81 PMID: 4045429
  268. Decreased virulence of recombinant vaccinia virus expression vectors is associated with a thymidine kinase-negative phenotype.
    Nature. 1985 Oct 31-Nov 6;317(6040):813-5 PMID: 4058585
  269. Vaccinia virus antigens on the plasma membrane of infected cells. I. Viral antigens transferred from infecting virus particles and synthesized after infection.
    Virology. 1985 Mar;141(2):201-20 PMID: 4082499
  270. Mechanism of virus occlusion into A-type inclusion during poxvirus infection.
    Virology. 1977 Jan;76(1):217-33 PMID: 835231
  271. Is cowpox misnamed? A review of 10 human cases.
    Br Med J. 1977 May 28;1(6073):1379-81 PMID: 861644
  272. Ultrastructural characterization of the Molluscum contagiosum virus genome.
    Virology. 1977 Sep;81(2):247-56 PMID: 898660
  273. Interferon, double-stranded RNA and RNA degradation. Characteristics of an endonuclease activity.
    Eur J Biochem. 1977 Oct 3;79(2):565-77 PMID: 923567
  274. Biogenesis of vaccinia: relationship of the envelope to virus assembly.
    Virology. 1976 Nov;75(1):242-55 PMID: 982852
  275. Lymphocyte and macrophage responses after vaccinia virus infections.
    Infect Immun. 1976 Oct;14(4):1014-21 PMID: 992867
  276. Genes required for cytotoxicity against virus-infected target cells in K and D regions of H-2 complex.
    Nature. 1975 Mar 20;254(5497):269-70 PMID: 1078719
  277. The prevention of early vaccinia-virus-induced cytopathic effects by inhibition of protein synthesis.
    J Gen Virol. 1968 Jul;3(1):51-61 PMID: 4234470
  278. Fate of intravenously administered interferon and the distribution of interferon during virus infections in mice.
    Br J Exp Pathol. 1966 Apr;47(2):168-76 PMID: 4287567
  279. Experimental respiratory infection with poxviruses. I. Clinical virological and epidemiological studies.
    Br J Exp Pathol. 1966 Oct;47(5):453-65 PMID: 4288602
  280. Localization of nucleotide phosphohydrolase activity within vaccinia.
    Proc Natl Acad Sci U S A. 1968 Jul;60(3):845-52 PMID: 4299268
  281. Effect of poxvirus infection on host cell deoxyribonucleic acid synthesis.
    J Virol. 1968 May;2(5):401-8 PMID: 4301310
  282. Relative sensitivities of viruses to different species of interferon.
    J Virol. 1969 Aug;4(2):147-53 PMID: 4308914
  283. Peroxidase-mediated virucidal systems.
    Science. 1970 Jan 9;167(3915):195-6 PMID: 4311694
  284. Growth kinetics of Yaba tumor poxvirus after in vitro adaptation to cercopithecus kidney cells.
    J Virol. 1970 Feb;5(2):205-11 PMID: 4317347
  285. Mechanisms of recovery from a generalized viral infection: mousepox. I. The effects of anti-thymocyte serum.
    J Exp Med. 1970 Nov;132(5):1035-54 PMID: 4319373
  286. Mechanisms of recovery from a generalized viral infection: mousepox. II. Passive transfer of recovery mechanisms with immune lymphoid cells.
    J Exp Med. 1971 May 1;133(5):1074-89 PMID: 4324300
  287. Mechanism of enhanced plaque formation by poliovirus in poxvirus-infected cells.
    J Gen Virol. 1972 Mar;14(3):237-42 PMID: 4336519
  288. Sensitivity of ribonucleic acid and deoxyribonucleic acid viruses to different species of interferon in cell cultures.
    J Virol. 1972 Aug;10(2):171-8 PMID: 4342236
  289. Role of humoral and cell-mediated immunity on the recovery of chickens from fowlpox virus infection.
    J Immunol. 1973 Nov;111(5):1495-501 PMID: 4355425
  290. An experimental study of the pathogenesis of fowlpox infection in chickens.
    Avian Dis. 1973 Jul-Sep;17(3):532-9 PMID: 4355963
  291. Novel 2',5'-oligoadenylates synthesized in interferon-treated, vaccinia virus-infected cells.
    J Virol. 1985 Dec;56(3):1041-4 PMID: 2415713
  292. Lymphocyte recruitment in vaccinia virus-induced cutaneous delayed-type hypersensitivity.
    Immunology. 1986 May;58(1):87-94 PMID: 2423440
  293. Delayed hypersensitivity in vaccinia-infected mice. I. Antigen(s) responsible for developing delayed hypersensitivity.
    Acta Virol. 1969 Nov;13(6):532-7 PMID: 4391721
  294. Biogenesis of vaccinia: concerning the origin of the envelope phospholipids.
    Virology. 1974 Dec;62(2):293-306 PMID: 4473861
  295. Biogenesis of poxviruses: inactivation of host DNA polymerase by a component of the invading inoculum particle.
    Proc Natl Acad Sci U S A. 1973 Jun;70(6):1726-9 PMID: 4515931
  296. Interferon inhibits viral protein synthesis in L cells infected with vaccinia virus.
    Nature. 1972 Aug 18;238(5364):385-8 PMID: 4559581
  297. Specific macrophage immunity to vaccinia virus: macrophage-virus interaction.
    Infect Immun. 1972 Jul;6(1):9-16 PMID: 4564156
  298. Lipids in viruses.
    Adv Lipid Res. 1973;11(0):267-339 PMID: 4607849
  299. Depressed cell-mediated immunity in newborn rabbits bearing fibroma virus-induced tumors.
    Infect Immun. 1973 Apr;7(4):613-9 PMID: 4762114
  300. Letter: Protein cleavage and poxvirus morphogenesis: tryptic peptide analysis of core precursors accumulated by blocking assembly with rifampicin.
    J Mol Biol. 1973 Dec 5;81(2):267-9 PMID: 4777308
  301. Interferon production by macrophages from adult and newborn rabbits bearing fibroma virus-induced tumors.
    Infect Immun. 1974 Apr;9(4):669-73 PMID: 4822868
  302. A study of delayed hypersensitivity of guinea pigs to vaccinia virus. Comparison of inhibition of cell migration to a local passive transfer reaction for the quantification of delayed hypersensitivity.
    Int Arch Allergy Appl Immunol. 1970;37(4):337-43 PMID: 4903805
  303. Molluscum contagiosum.
    Arch Environ Health. 1970 Sep;21(3):432-52 PMID: 4926862
  304. Biogenesis of poxviruses: role of A-type inclusions and host cell membranes in virus dissemination.
    Virology. 1971 Dec;46(3):507-32 PMID: 4944855
  305. Demonstration of vaccinia, lymphocytic choriomeningitis and rabies viruses in the leucocytes of experimentally infected animals.
    Arch Gesamte Virusforsch. 1965;17(2):273-9 PMID: 4956729
  306. Effect of neonatal thymectomy and thiotepa on the susceptibility of mice to the lethal effects of poxviruses.
    Aust J Exp Biol Med Sci. 1968 Jun;46(3):267-72 PMID: 4971284
  307. The synthesis of poxvirus-specific RNA in interferon-treated cells.
    Virology. 1972 Apr;48(1):59-70 PMID: 5062860
  308. Role of basophilic leukocytes in cellular immunity to vaccinia virus infection.
    J Immunol. 1971 Dec;107(6):1576-82 PMID: 5120398
  309. Morphogenesis of rabbit fibroma virus. Correlation with pathogenesis of the skin lesion.
    Am J Pathol. 1971 Sep;64(3):467-78 PMID: 5133512
  310. The antibody response of rabbits to inactivated vaccinia virus.
    J Hyg (Lond). 1965 Dec;63(4):525-35 PMID: 5215639
  311. Effects of streptovitacin A on the initial events in the replication of vaccinia and reovirus.
    Proc Natl Acad Sci U S A. 1965 Aug;54(2):462-8 PMID: 5217434
  312. Complement requirement of the neutralizing antibody appearing after immunization with smallpox vaccine.
    Jpn J Microbiol. 1968 Jun;12(2):256-9 PMID: 5303512
  313. Studies on the nature of Marchal bodies (A-type inclusion) during ectromelia virus infection.
    Virology. 1966 Jun;29(2):264-75 PMID: 5329147
  314. Cell-mediated immune responses to virus infections and virus-induced tumours.
    Br Med Bull. 1967 Jan;23(1):60-5 PMID: 5342382
  315. Interruption by Rifampin of an early stage in vaccinia virus morphogenesis: accumulation of membranes which are precursors of virus envelopes.
    J Virol. 1970 Oct;6(4):519-33 PMID: 5497899
  316. Metabolic properties of early and late vaccinia virus messenger ribonucleic acid.
    J Virol. 1967 Jun;1(3):550-8 PMID: 5623973
  317. Cellular immunity in vaccinia infection of mice. Anti-thymocyte serum effects on primary and secondary responsiveness.
    J Exp Med. 1968 Jul 1;128(1):121-32 PMID: 5662010
  318. Inhibition by interferon of the uncoating of vaccinia virus.
    Virology. 1968 Aug;35(4):505-11 PMID: 5677798
  319. The immunodepressive action of lymphocytic choriomeningitis virus in mice.
    J Immunol. 1968 Oct;101(4):717-24 PMID: 5681651
  320. Inhibition of HeLa cell protein synthesis by the vaccinia virion.
    J Virol. 1968 Oct;2(10):1028-37 PMID: 5723706
  321. Ultrastructural changes in dermal and eipidermal cells of skin infected with Molluscum contagiosum virus.
    J Ultrastruct Res. 1969 Feb;26(3):177-96 PMID: 5776617
  322. THE CYCLE OF MULTIPLICATION OF VACCINIA VIRUS IN EARLE'S STRAIN L CELLS. I. UPTAKE AND PENETRATION.
    Virology. 1964 Nov;24:278-94 PMID: 14227031
  323. LEUKOCYTES AND INTERFERON IN THE HOST RESPONSE TO VIRAL INFECTIONS. I. MOUSE LEUKOCYTES AND LEUKOCYTE-PRODUCED INTERFERON IN VACCINIA VIRUS INFECTION IN VITRO.
    J Exp Med. 1965 Jun 1;121:1001-18 PMID: 14319399
  324. Studies smallpox and complications of smallpox vaccination.
    Pediatrics. 1960 Aug;26:176-89 PMID: 14408455
  325. Hybridization and sedimentation studies on "early" and "late" vaccinia messenger RNA.
    J Mol Biol. 1967 Aug 14;27(3):395-419 PMID: 6049681
  326. Strain differences in Shope fibroma virus. An immunopathologic study.
    Am J Pathol. 1984 Aug;116(2):342-58 PMID: 6087669
  327. Evaluation of hamster natural cytotoxic cells and vaccinia-induced cytotoxic cells for Thy-1.2 homologue by using a mouse monoclonal alpha-Thy-1.2 antibody.
    J Immunol. 1982 Nov;129(5):2239-43 PMID: 6126504
  328. Induction of Thy-1.2 homologue-positive and Thy-1.2 homologue-negative nonspecific cytotoxic lymphocytes in the hamster.
    J Immunol. 1983 Aug;131(2):622-7 PMID: 6134772
  329. Synergic effects of interferon and interferon inducer against ectromelia virus infection in mice.
    Biken J. 1980 Jun;23(2):77-81 PMID: 6161603
  330. Combined protective effects on interferon and interferon induction on herpes simplex and ectromelia virus infections in mice.
    Antimicrob Agents Chemother. 1981 May;19(5):922-4 PMID: 6170256
  331. Modification of membrane permeability in vaccinia virus-infected cells.
    Virology. 1982 Feb;117(1):62-9 PMID: 6175088
  332. Characteristics of poxvirus-induced meningitis: virus-specific and non-specific cytotoxic effectors in the inflammatory exudate.
    Scand J Immunol. 1983 Jul;18(1):1-7 PMID: 6192487
  333. Nonspecific cytotoxicity of vaccinia-induced peritoneal exudates in hamsters is mediated by Thy-1.2 homologue-positive cells distinct from NK cells and macrophages.
    J Immunol. 1983 Nov;131(5):2545-50 PMID: 6195269
  334. Reversal of virus-induced immune suppression.
    J Immunol. 1986 Apr 1;136(7):2649-53 PMID: 3005416
  335. Nucleotide sequence of the vaccinia virus hemagglutinin gene.
    Virology. 1986 Apr 30;150(2):451-62 PMID: 3008418
  336. Poxvirus infection in the domestic cat: some clinical and epidemiological observations.
    Vet Rec. 1986 Apr 5;118(14):387-90 PMID: 3012851
  337. Insertion and deletion mutants of vaccinia virus.
    Virology. 1986 Jul 30;152(2):285-97 PMID: 3014720
  338. Tumorigenic poxviruses: analysis of viral DNA sequences implicated in the tumorigenicity of Shope fibroma virus and malignant rabbit virus.
    Virology. 1986 Jul 30;152(2):308-21 PMID: 3014722
  339. Variable resistance to ectromelia (mousepox) virus among genera of Mus.
    Curr Top Microbiol Immunol. 1986;127:319-22 PMID: 3015497
  340. DNA sequence homology between the terminal inverted repeats of Shope fibroma virus and an endogenous cellular plasmid species.
    Mol Cell Biol. 1986 Jan;6(1):265-76 PMID: 3023828
  341. Immunologic requirements for the adoptive transfer of ectromelia virus meningitis.
    J Neuropathol Exp Neurol. 1982 Jan;41(1):18-33 PMID: 6275036
  342. Pathology and diagnosis of mousepox.
    Lab Anim Sci. 1981 Oct;31(5 Pt 2):599-608 PMID: 6281565
  343. A novel cell transformation with DNA-containing cytoplasmic Yaba tumor poxvirus.
    Virology. 1982 Jul 15;120(1):77-92 PMID: 6285604
  344. Natural killer (NK) cells as a responder to interleukin 2 (IL 2). II. IL 2-induced interferon gamma production.
    J Immunol. 1983 Feb;130(2):988-92 PMID: 6294182
  345. Discriminatory inhibition of protein synthesis in cell-free systems by vaccinia virus transcripts.
    Proc Natl Acad Sci U S A. 1983 Jan;80(1):75-9 PMID: 6296875
  346. The white pock mutants of rabbit poxvirus: V. In vitro translation of early host range mutant mRNA.
    Virology. 1983 Apr 15;126(1):381-90 PMID: 6302993
  347. Malignant rabbit fibroma virus: observations on the culture and histopathologic characteristics of a new virus-induced rabbit tumor.
    J Natl Cancer Inst. 1983 Jul;71(1):91-104 PMID: 6306326
  348. Mechanisms determining innate resistance to ectromelia virus infection in C57BL mice.
    Infect Immun. 1983 Sep;41(3):1391-4 PMID: 6309671
  349. Mechanism of protection during the early phase of a generalized viral infection. I. Contribution of phagocytes to protection against ectromelia virus.
    J Gen Virol. 1983 Sep;64 (Pt 9):2021-6 PMID: 6310039
  350. Marker rescue of temperature-sensitive mutations of vaccinia virus WR: correlation of genetic and physical maps.
    J Virol. 1983 Nov;48(2):419-28 PMID: 6312100
  351. Activation of chicken alternative complement pathway by fowlpox virus-infected cells.
    Infect Immun. 1983 Nov;42(2):721-7 PMID: 6315584
  352. Evaluation of an enzyme-linked immunosorbent assay for the detection of ectromelia (mousepox) antibody.
    J Clin Microbiol. 1983 Nov;18(5):1220-5 PMID: 6315770
  353. Selective transcription of vaccinia virus genes in template dependent soluble extracts of infected cells.
    Cell. 1983 Dec;35(2 Pt 1):441-8 PMID: 6317189
  354. Resistance of vaccinia virus to interferon is related to an interference phenomenon between the virus and the interferon system.
    Virology. 1984 Apr 15;134(1):12-28 PMID: 6324465
  355. T-T cell interaction in the in vitro induction of delayed-type hypersensitivity (DTH) responses: demonstration of vaccinia virus-reactive helper T cell activity involved in enhanced induction of DTH responses.
    J Leukoc Biol. 1985 May;37(5):629-39 PMID: 3156939
  356. Molecular epidemiology of molluscum contagiosum.
    J Infect Dis. 1988 Oct;158(4):898-900 PMID: 3171236
  357. Glycoprotein C of herpes simplex virus 1 acts as a receptor for the C3b complement component on infected cells.
    Nature. 1984 Jun 14-20;309(5969):633-5 PMID: 6328323
  358. Vaccinia virus 19-kilodalton protein: relationship to several mammalian proteins, including two growth factors.
    Proc Natl Acad Sci U S A. 1984 Dec;81(23):7363-7 PMID: 6334307
  359. Hierarchies of T cell responsiveness are reflected in the distribution of effector T cells in viral meningitis.
    Aust J Exp Biol Med Sci. 1983 Aug;61 (Pt 4):471-5 PMID: 6418125
  360. Hamster T cells participate in MHC alloimmune reactions but do not effect virus-induced cytotoxic activity.
    Immunogenetics. 1980 Jul;11(1):75-86 PMID: 6449478
  361. Isolation, characterization, and physical mapping of temperature-sensitive mutants of vaccinia virus.
    Virology. 1983 Jul 30;128(2):429-43 PMID: 6577746
  362. Mutation of antitrypsin to antithrombin. alpha 1-antitrypsin Pittsburgh (358 Met leads to Arg), a fatal bleeding disorder.
    N Engl J Med. 1983 Sep 22;309(12):694-8 PMID: 6604220
  363. Immune response against vaccinia virus in rhesus monkeys: no evidence for primary MHC-restricted cytolytic T cells.
    Exp Cell Biol. 1984;52(4):237-50 PMID: 6610578
  364. Inhibition of the elongation step of protein synthesis by vaccinia virus.
    FEBS Lett. 1983 Mar 21;153(2):427-30 PMID: 6617871
  365. Interferon-mediated, double-stranded RNA-dependent protein kinase is inhibited in extracts from vaccinia virus-infected cells.
    J Virol. 1984 Apr;50(1):229-36 PMID: 6699945
  366. Persistent infection of Friend erythroleukemia cells with vaccinia virus.
    Proc Natl Acad Sci U S A. 1982 Aug;79(15):4805-9 PMID: 6956893
  367. Shut-off of host protein synthesis in vaccinia-virus-infected cells exposed to cordycepin. A study in vitro.
    Eur J Biochem. 1980 Jan;103(1):85-93 PMID: 6965641
  368. Virus-specific proliferative T-cell responses: parameters and specificity.
    Cell Immunol. 1980 Aug 1;53(2):267-84 PMID: 6967765
  369. Inhibition of 40S--Met--tRNAfMet ribosomal initiation complex formation by vaccinia virus.
    Nature. 1980 Sep 25;287(5780):355-7 PMID: 6968407
  370. Immune response in rabbits to surface components of extracellular and intracellular forms of vaccinia virus.
    Infect Immun. 1980 Sep;29(3):846-52 PMID: 7000705
  371. Cell-mediated immune response to Shope fibroma virus-induced tumors in adult rabbits.
    J Natl Cancer Inst. 1981 Apr;66(4):681-9 PMID: 7014966
  372. The complement system: its importance in the host response to viral infection.
    Microbiol Rev. 1982 Mar;46(1):71-85 PMID: 7045625
  373. Interactions between human neutrophils and vaccinia virus: induction of oxidative metabolism and virus inactivation.
    Pediatr Res. 1982 Jul;16(7):525-9 PMID: 7110771
  374. Vaccinia virus-induced changes in [Na+] and [K+] in HeLa cells.
    J Gen Virol. 1982 Sep;62 (Pt 1):127-36 PMID: 7130948
  375. Characterization of vaccinia polypeptides.
    Virology. 1981 Aug;113(1):263-76 PMID: 7269242
  376. Characterization of intracellular and extracellular vaccinia virus variants: N1-isonicotinoyl-N2-3-methyl-4-chlorobenzoylhydrazine interferes with cytoplasmic virus dissemination and release.
    J Virol. 1981 Sep;39(3):903-13 PMID: 7288920
  377. Adsorption and penetration of the trypsinized vaccinia virion.
    Virology. 1980 Feb;101(1):50-60 PMID: 7355578
  378. The antigenicity and immunogenicity of the intracellular and extracellular forms of vaccinia virus. I: The production of high-titre vaccinia extracellular virus and its antigenicity after inactivation.
    Br J Exp Pathol. 1980 Aug;61(4):444-50 PMID: 7426394
  379. Two heat-labile factors in normal sera which neutralize variola virus.
    Br J Exp Pathol. 1952 Dec;33(6):529-36 PMID: 13009039
  380. The pathogenesis of infectious myxomatosis; the mechanism of infection and the immunological response in the European rabbit (Oryctolagus cuniculus).
    Br J Exp Pathol. 1953 Aug;34(4):400-11 PMID: 13093911
  381. Studies in the epidemiology of infectious myxomatosis of rabbits. II. Field experiments, August-November 1950, and the first epizootic of myxomatosis in the Riverine Plain of south-eastern Australia.
    J Hyg (Lond). 1954 Mar;52(1):47-59 PMID: 13152364
  382. The role of genotype in resistance to an epizootic of mouse pox (ectromelia).
    Am J Hyg. 1956 Jan;63(1):59-68 PMID: 13282888
  383. A short description of the poxvirus group (vaccinia and related viruses).
    Virology. 1957 Oct;4(2):305-14 PMID: 13496547
  384. The antibody response in man following infection with viruses of the pox group. I. An evaluation of the pock counting method for measuring neutralizing antibody.
    J Hyg (Lond). 1958 Mar;56(1):84-100 PMID: 13525719
  385. The biological characters of several strains of vaccinia, cowpox and rabbitpox viruses.
    Virology. 1958 Jun;5(3):502-29 PMID: 13557734
  386. The response of mice to large intravenous injections of ectromelia virus. I. The fate of injected virus.
    Br J Exp Pathol. 1959 Dec;40:533-42 PMID: 14422711
  387. The response of mice to large intravenous injections of ectromelia virus. II. The growth of virus in the liver.
    Br J Exp Pathol. 1959 Dec;40:543-50 PMID: 14422712
  388. Morphological studies of orf and vaccinia viruses.
    Virology. 1962 Mar;16:248-60 PMID: 14477954
  389. Studies on vaccinia virus. II. Neutralization of vaccinia virus by normal guinea pig serum.
    J Immunol. 1951 Nov;67(5):413-22 PMID: 14898077
  390. A variant of cowpox virus.
    Lancet. 1952 May 24;1(6717):1049-50 PMID: 14928559
  391. [The reinfestation of Indonesia with the smallpox].
    Ned Tijdschr Geneeskd. 1949 Oct 29;93(44):3686-95 PMID: 15394778
  392. Messenger RNA synthesis by a "coated" viral genome.
    Proc Natl Acad Sci U S A. 1967 Feb;57(2):314-20 PMID: 16591471
  393. Studies on Filterable Viruses: III. Further Observations on Vaccine Virus.
    Am J Pathol. 1929 Mar;5(2):147-55 PMID: 19969838
  394. Kinetics of cytotoxic lymphocytes in efferent lymph from single lymph nodes following immunization with vaccinia virus.
    Clin Exp Immunol. 1984 Jun;56(3):515-23 PMID: 6204794
  395. Indiscriminate degradation of RNAs in interferon-treated, vaccinia virus-infected mouse L cells.
    J Virol. 1984 Sep;51(3):866-71 PMID: 6206238
  396. Complement ligand-receptor interactions that mediate biological responses.
    Annu Rev Immunol. 1983;1:243-71 PMID: 6242465
  397. The white pock mutants of rabbit poxvirus. I. Spontaneous host range mutants contain deletions.
    Virology. 1980 Apr 15;102(1):119-32 PMID: 6245500
  398. Comparison of white pock (h) mutants of monkeypox virus with parental monkeypox and with variola-like viruses isolated from animals.
    Nature. 1980 Jul 3;286(5768):29-32 PMID: 6248794
  399. Studies on poxvirus infections in irradiated animals.
    Arch Virol. 1980;64(3):247-56 PMID: 6250514
  400. The white pock (mu) mutants of rabbit poxvirus. III. Terminal DNA sequence duplication and transposition in rabbit poxvirus.
    Cell. 1980 Nov;22(2 Pt 2):545-53 PMID: 6256085
  401. Host range deletion mutant of vaccinia virus defective in human cells.
    Virology. 1981 Jun;111(2):488-99 PMID: 6264670
  402. Subcutaneous "growths" in monkeys produced by a poxvirus.
    J Pathol Bacteriol. 1961 Jan;81:1-14 PMID: 13729313
  403. Studies on the innate resistance of mice to infection with mousepox. II. Route of inoculation and resistance; and some observations on the inheritance of resistance.
    Aust J Exp Biol Med Sci. 1960 Aug;38:289-99 PMID: 13747447
  404. Biological studies of interferon. I. Suppression of cellular infection with eastern equine encephalomyelitis virus.
    Virology. 1961 Mar;13:323-37 PMID: 13782523
  405. A study with the electron microscope of the skin tumour of molluscum contagiosum.
    J Ultrastruct Res. 1959 Oct;3:11-38 PMID: 13817859
  406. Effect of a primary tuberculous infection on the resistance of male and female mice to Ectromelia.
    Nature. 1960 Aug 20;187:703-4 PMID: 13828410
  407. Analysis of the early stages of vaccinia virus infection in KB cells using sodium azide.
    Virology. 1961 Dec;15:417-27 PMID: 13888966
  408. The reactivation of animal viruses.
    Br Med J. 1962 Jul 21;2(5298):135-42 PMID: 13892286
  409. The role of antibody in recovery from infection with vaccinia virus.
    J Immunol. 1961 Oct;87:379-82 PMID: 13895286
  410. The role of antibody, delayed hypersensitivity, and interferon production in recovery of guinea pigs from primary infection with vaccinia virus.
    J Exp Med. 1962 Sep 1;116:347-56 PMID: 13895287
  411. An antigenic difference between intracellular and extracellular rabbitpox virus.
    J Gen Virol. 1971 Oct;13(1):9-17 PMID: 4108676
  412. Biogenesis of poxviruses: interrelationship between hemagglutinin production and polykaryocytosis.
    Virology. 1971 Dec;46(3):533-43 PMID: 4109523
  413. Uncoating of poxviruses. I. Detection and characterization of subviral particles in the uncoating process.
    Virology. 1972 Oct;50(1):216-32 PMID: 4117124
  414. Studies on the nature and location of the capsid polypeptides of vaccinia virions.
    Virology. 1972 Nov;50(2):579-92 PMID: 4117937
  415. Macrophage immunity to vaccina virus: factors affecting macrophage immunity in vitro.
    J Reticuloendothel Soc. 1974 Jul;16(1):37-47 PMID: 4137839
  416. Effect of measles vaccine on immunologic responsiveness.
    Pediatrics. 1969 Feb;43(2):264-72 PMID: 4179145
  417. Effect of heat-labile factors on the neutralization of vaccinia virus by human.
    Infect Immun. 1973 Oct;8(4):582-9 PMID: 4200542
  418. Nature and mode of action of vaccinia virus products that block activation of the interferon-mediated ppp(A2'p)nA-synthetase.
    Virology. 1984 Apr 15;134(1):29-39 PMID: 6324475
  419. In vitro cellular immunity to unrelated pathogens in chickens infected with fowlpox virus.
    Infect Immun. 1974 Jul;10(1):34-41 PMID: 4366915
  420. Induction of both thymidine and deoxycytidine kinase activity by herpes viruses.
    J Gen Virol. 1974 Sep;24(3):465-80 PMID: 4372299
  421. The role of interferon in vaccinia virus infection of mouse embryo tissue culture.
    J Exp Med. 1962 Mar 1;115:503-12 PMID: 13899115
  422. The role of hypersensitivity in the pathogenesis of vaccinia virus infection in humans.
    J Pediatr. 1963 Jan;62:57-62 PMID: 13943652
  423. Interferon production by mouse leukocytes in vitro and in vivo.
    J Exp Med. 1963 Jan 1;117:149-60 PMID: 13948365
  424. Rabbit pox: an experimental study of the pathways of infection in rabbits.
    J Pathol Bacteriol. 1963 Jan;85:1-20 PMID: 13970225
  425. Histopathogenesis of mousepox. II. Cutaneous infection.
    Br J Exp Pathol. 1962 Oct;43:462-8 PMID: 13974309
  426. Histopathogenesis of mousepox. I. Respiratory infection.
    Br J Exp Pathol. 1962 Oct;43:451-61 PMID: 13974310
  427. The formation of vaccinia virus protein in the presence of 5-fluorodeoxyuridine.
    Virology. 1963 Jun;20:292-301 PMID: 13976928
  428. The pathogenesis of Yaba virus-induced histiocytomas in primates.
    Cancer Res. 1963 Jun;23:671-5 PMID: 13978564
  429. Serological relationships within the poxvirus group: an antigen common to all members of the group.
    Virology. 1962 Mar;16:334-41 PMID: 14008226
  430. The toxic effect of rabbitpox virus in tissue culture.
    Virology. 1962 Oct;18:159-69 PMID: 14013492
  431. The uptake and development of vaccinia virus in strain L cells followed with labeled viral deoxyribonucleic acid.
    J Cell Biol. 1963 Jul;18:51-72 PMID: 14024720
  432. Biochemistry of vaccinia-infected mouse fibroblasts (strain L-M). I. Effects on nucleic acid and protein synthesis.
    Virology. 1962 Oct;18:274-85 PMID: 14033129
  433. THE RESPONSE OF INBRED RABBITS TO VACCINIA VIRUS INFECTION.
    J Immunol. 1963 Jul;91:58-64 PMID: 14056373
  434. HISTOPATHOGENESIS OF MOUSEPOX: III. ECTROMELIA VIRULENCE.
    Br J Exp Pathol. 1963 Oct;44:465-72 PMID: 14066120
  435. EFFECT OF IMMUNIZATION ON TISSUE SUSCEPTIBILITY TO VACCINIA VIRUS IN VITRO.
    Virology. 1963 Nov;21:402-10 PMID: 14081365
  436. HUMAN SUSCEPTIBILITY TO A SIMIAN TUMOR VIRUS.
    Ann N Y Acad Sci. 1963 Nov 4;108:1123-8 PMID: 14081494
  437. PROGRESSIVE VACCINIA WITH NORMAL ANTIBODIES. A CASE POSSIBLY DUE TO DEFICIENT CELLULAR IMMUNITY.
    Ann Intern Med. 1964 Feb;60:282-9 PMID: 14114447
  438. STUDIES ON THE STRUCTURE OF VACCINIA VIRUS.
    J Gen Microbiol. 1964 Jan;34:67-78 PMID: 14121221
  439. ASPECTS OF THE PATHOGENESIS OF VIRUS DISEASES.
    Bacteriol Rev. 1964 Mar;28:30-71 PMID: 14127970
  440. A PROTECTIVE ANTIGEN FROM THE POX-VIRUSES. I. REACTION WITH NEUTRALIZING ANTIBODY.
    Br J Exp Pathol. 1964 Apr;45:150-61 PMID: 14140751
  441. SHOPE FIBROMA AND RABBIT MYXOMA VIRUSES. II. PATHOGENESIS OF FIBROMAS IN DOMESTIC RABBITS.
    Biken J. 1963 Jul;6:135-43 PMID: 14147700
  442. MESSENGER RNA IN CELLS INFECTED WITH VACCINIA VIRUS.
    Proc Natl Acad Sci U S A. 1964 Apr;51:577-85 PMID: 14166765
  443. THE SYNTHESIS OF A DNA-LIKE RNA IN THE CYTOPLASM OF HELA CELLS INFECTED WITH VACCINIA VIRUS.
    J Mol Biol. 1964 Mar;8:405-16 PMID: 14168694
  444. HYBRIDS DERIVED FROM THE VIRUSES OF VARIOLA MAJOR AND COWPOX.
    J Hyg (Lond). 1964 Jun;62:147-58 PMID: 14171267
  445. THE INTRACELLULAR FATE OF RABBITPOX VIRUS RENDERED NONINFECTIOUS BY VARIOUS REAGENTS.
    Virology. 1964 Apr;22:620-33 PMID: 14171601
  446. A QUANTITATIVE CELL CULTURE ASSAY FOR YABA TUMOUR VIRUS.
    Nature. 1964 May 30;202:881-3 PMID: 14190079
  447. GROWTH OF ECTROMELIA VIRUS IN THE LIVER PARENCHYMAL CELLS OF DIFFERENT STRAINS OF MOUSE.
    Nature. 1964 Jun 13;202:1140-1 PMID: 14207232
  448. INHIBITORY EFFECT OF INTERFERON ON THE INDUCTION OF THYMIDINE KINASE IN VACCINIA VIRUS-INFECTED CHICK EMBRYO FIBROBLASTS.
    Acta Virol. 1964 Sep;8:479 PMID: 14209642
  449. GROWTH OF VIRULENT AND ATTENUATED ECTROMELIA VIRUS IN CULTURED MACROPHAGES FROM NORMAL AND ECTROMELIAIMMUNE MICE.
    J Immunol. 1964 Jun;92:837-42 PMID: 14210788
Article Info
Journal
Microbiological reviews
Abbr.
Microbiol Rev
ISSN
0146-0749
Published
1991-03-00
Pages
80-122
Language
English
Region
United States
NLM ID
7806086
PMCID
PMC372802
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]